Margo J H van Campenhout (Margo J van Campenhout)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Journal of viral hepatitis

Alimentary pharmacology & therapeutics

Scientific reports

Hepatology (Baltimore, Md.)

Reinier de Graaf Gasthuis

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Reinier de Graaf Gasthuis Aug 01 2019

Netherlands

Resident Gastroenterology and Hepatology :: Gastroenterology & Hepatology

Erasmus MC Dec 01 2013

Netherlands

Researcher :: Gastroenterology & Hepatology

Reinier de Graaf Groep May 01 2017 - May 01 2019

Netherlands

Resident Gastroenterology and Hepatology :: Internal Medicine

Publications

Mina S Farag, Margo J H van Campenhout, Milan J Sonneveld, Scott Fung, Karel J van Erpecum, David K Wong, Elke Verhey, Robert de Man, Robert J De Knegt, Johannes T Brouwer, Hubertus C Baak, Jordan J Feld, Kin Seng Liem, André Boonstra, Bettina E Hansen, Harry L A Janssen
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study). Journal of viral hepatitis 31 (4) (2024)
Mina S Farag, Margo J H van Campenhout, Milan J Sonneveld, Scott Fung, Karel J van Erpecum, David K Wong, Elke Verhey, Robert de Man, Robert J De Knegt, Johannes T Brouwer, Hubertus C Baak, Jordan J Feld, Kin Seng Liem, André Boonstra, Bettina E Hansen, Harry L A Janssen
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study). Journal of viral hepatitis 31 (4) (2024)
Mina S Farag, Margo J H van Campenhout, Milan J Sonneveld, Scott Fung, Karel J van Erpecum, David K Wong, Elke Verhey, Robert de Man, Robert J De Knegt, Johannes T Brouwer, Hubertus C Baak, Jordan J Feld, Kin Seng Liem, André Boonstra, Bettina E Hansen, Harry L A Janssen
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study). Journal of viral hepatitis (2024)
Mina S Farag, Margo J H van Campenhout, Milan J Sonneveld, Scott Fung, Karel J van Erpecum, David K Wong, Elke Verhey, Robert de Man, Robert J De Knegt, Johannes T Brouwer, Hubertus C Baak, Jordan J Feld, Kin Seng Liem, André Boonstra, Bettina E Hansen, Harry L A Janssen
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study). Journal of viral hepatitis 31 (4) (2024)
Sylvia M Brakenhoff, Robert A de Man, André Boonstra, Margo J H van Campenhout, Robert J de Knegt, Florian van Boemmel, Annemiek A van der Eijk, Thomas Berg, Bettina E Hansen, Harry L A Janssen, Milan J Sonneveld
Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss. Alimentary pharmacology & therapeutics 53 (2) (2020)
Margo J H van Campenhout, Florian van Bömmel, Maria Pfefferkorn, Janett Fischer, Danilo Deichsel, André Boonstra, Anneke J van Vuuren, Thomas Berg, Bettina E Hansen, Harry L A Janssen
Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg-positive chronic hepatitis B. Journal of viral hepatitis 27 (6) (2020)
Kin Seng Liem, Margo J H van Campenhout, Qing Xie, Willem Pieter Brouwer, Heng Chi, Xun Qi, Liang Chen, Fehmi Tabak, Bettina E Hansen, Harry L A Janssen
Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B. Alimentary pharmacology & therapeutics 49 (4) (2020)
Margo J H van Campenhout, Vincent Rijckborst, Willem Pieter Brouwer, Gertine W van Oord, Peter Ferenci, Fehmi Tabak, Meral Akdogan, Binnur Pinarbasi, Krzysztof Simon, Robert J de Knegt, André Boonstra, Harry L A Janssen, Bettina E Hansen
Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B. Journal of viral hepatitis 26 (10) (2019)
Alan J Mueller, Fernando Garcia-Alcalde, Steffen Wildum, Saskia L Smits, Robert A de Man, Margo J H van Campenhout, Willem Pieter Brouwer, Jianjun Niu, John A T Young, Isabel Najera, Lina Zhu, Daitze Wu, Tomas Racek, Gadissa Bedada Hundie, Yong Lin, Charles A Boucher, David van de Vijver, Bart L Haagmans
Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts. Scientific reports 9 (1) (2019)
Milan J Sonneveld, Gertine W van Oord, Margo J H van Campenhout, Robert A De Man, Harry L A Janssen, Robert J de Knegt, André Boonstra, Annemiek A van der Eijk
Relationship between hepatitis B core-related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analogues. Journal of viral hepatitis 26 (7) (2019)
Margo J H van Campenhout, Willem Pieter Brouwer, Qing Xie, S Guo, Heng Chi, Xun Qi, Fehmi Tabak, Adrian Streinu-Cercel, Ji-Yao Wang, Ning-Ping Zhang, Ramazan Idilman, Hendrik W Reesink, Mircea Diculescu, Krzysztof Simon, Meral Akdogan, Włodzimierz Mazur, Rob J de Knegt, Elke Verhey, Bettina E Hansen, Harry L A Janssen, null null
Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up. Journal of viral hepatitis 26 (1) (2018)
Margo J H van Campenhout, Florian van Bömmel, Maria Pfefferkorn, Janett Fischer, Danilo Deichsel, André Boonstra, Anneke J van Vuuren, Thomas Berg, Bettina E Hansen, Harry L A Janssen
Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment. Hepatology (Baltimore, Md.) 68 (3) (2018)

Margo J H van Campenhout.css-eqlu8i{font-size:small;padding-left:4px;} (Margo J van Campenhout)

Publication Activity (10 Years)

Top Topics

Top Venues

Margo J H van Campenhout (Margo J van Campenhout)